Evaluating the effects of testing period on pollinosis symptoms using an allergen challenge chamber

Allergology International

Volumn 60, Issue 4, 2011, Pages 533-539

  Yuki, Ayumi ^a   Terada, Tetsuya ^a   Ichihara, Takahiro ^a   Fujii, Kanako ^a   Hyo, Sawako ^a   Kawata, Ryo ^a   Takenaka, Hiroshi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Allergen challenge chamber; Allergic reaction; Priming effect; Seasonal allergic rhinitis

Indexed keywords

ADULT; ALLERGEN CHALLENGE CHAMBER; ARTICLE; CROSS-SECTIONAL STUDY; EOSINOPHIL COUNT; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; JAPANESE CEDAR; MALE; NOSE CAVITY; NOSE MUCUS; NOSE OBSTRUCTION; OCULAR PRURITUS; POLLEN ALLERGY; PRIORITY JOURNAL; PROVOCATION TEST; RHINOMETRY; SEASONAL VARIATION; SNEEZING;

EID: 83455257993     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.10-OA-0264     Document Type: Article

References (17)

1. Enomoto T, Ide T, Ogino S. Construction of an environmental exposure unit and investigation of the effects of cetirizine hydrochloride on symptoms of cedar pollinosis in Japan. J Investig Allergol Clin Immunol 2007;17:173-81.
2. Stuck BA, Czajkowski J, Hagner AE et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol 2004;113:663-8.
3. Settipane RA. Complications of allergic rhinitis. Allergy Asthma Proc 1999;20:209-13.
4. Thompson AK, Juniper E, Meltzer EO. Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2000;85:338-47.
5. Schoenwetter WF, Dupclay L Jr, Appajosyula S, Botteman MF, Pashos CL. Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin 2004;20:305-17.
6. Hyo S, Fujieda S, Kawada R, Kitazawa S, Takenaka H. The efficacy of short-term administration of 3 antihistamines vs placebo under natural exposure to Japanese cedar pollen. Ann Allergy Asthma Immunol 2005;94:457-64.
7. Bronsky EA, Aaronson DW, Berkowitz RB et al. Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1997; 79:51-6.
8. Horak F, Stübner P, Zieglmayer R et al. Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis. Int Arch Allergy Immunol 2001; 125:73-9.
9. Day JH, Briscoe MP, Welsh A et al. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit. Ann Allergy Asthma Immunol 1997;79:533-40.
10. Krug N, Hohlfeld JM, Geldmacher H et al. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit. Allergy 2005;60:354-9.
11. Connell JT. Quantitative intranasal pollen changes. III. The priming effect in allergic rhinitis. J Allergy 1969;43: 33-44.
12. Kato M, Hattori T, Kitamura M, Beppu R, Yanagita N, Nakashima I. Soluble ICAM-1 as a regulator of nasal allergic reaction under natural allergen provocation. Clin Exp Allergy 1995;25:744-8.
13. Horak F, Jäger S. The Vienna challenge chamber (VCC)-a new method for allergen exposition test. Wien Klin Wochenschr 1987;99:509-10.
14. Horak F, Jäger S. VCC-Vienna challenge chamber-the protective effects of Astemizole. Allergy 1988;43 (Suppl 7):110.
15. Day JH, Briscoe MP. Environmental exposure unit: a system to test anti-allergic treatment. Ann Allergy Asthma Immunol 1999;83:83-9.
16. Ito K, Terada T, Yuki A et al. Preliminary study of a challenge test to the patients with Japanese cedar pollinosis using an environmental exposure unit. Auris Nasus Larynx 2010;37:694-9.
17. Day H, Horak F, Briscoe MP et al. The role of allergen challenge chamber in the evaluation of anti-allergic medication: an international consensus paper. Clin Exp Allergy Reviews 2006;6:31-59.